RUMI is a novel negative prognostic marker and therapeutic target in non–small‐cell lung cancer-Reference-Cited by-同舟云学术

RUMI is a novel negative prognostic marker and therapeutic target in non–small‐cell lung cancer

Published:2018-06-28 Issue:12 Volume:233 Page:9548-9562
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Chammaa May¹,Malysa Agnes²,Redondo Carlos¹,Jang Hyejeong³,Chen Wei²³⁴⁵,Bepler Gerold²⁴⁶,Fernandez‐Valdivia Rodrigo¹²⁴⁵^ORCID

Affiliation:

1. Department of Pathology Wayne State University School of Medicine Detroit Michigan

2. Department of Oncology Wayne State University School of Medicine Detroit Michigan

3. Biostatistics Core Barbara Ann Karmanos Cancer Institute Detroit Michigan

4. Cancer Biology Graduate Program Wayne State University School of Medicine Detroit Michigan

5. Tumor Biology and Microenvironment Program Barbara Ann Karmanos Cancer Institute Detroit Michigan

6. Molecular Therapeutics Program Barbara Ann Karmanos Cancer Institute Detroit Michigan

Funder

Wayne State University

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.26858

Reference66 articles.

1. Rumi Is a CAP10 Domain Glycosyltransferase that Modifies Notch and Is Required for Notch Signaling

2. Activated Notch1 Induces Lung Adenomas in Mice and Cooperates with Myc in the Generation of Lung Adenocarcinoma

3. Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS‐driven lung adenocarcinoma;Ambrogio C.;Nature Medicine (New York, NY, United States),2016

4. Comparative genomic hybridization analysis detects frequent, often high‐level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non‐small cell lung carcinomas;Balsara B. R.;Cancer Research,1997

5. Mutations in POGLUT1, Encoding Protein O-Glucosyltransferase 1, Cause Autosomal-Dominant Dowling-Degos Disease

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of the Notch signaling pathway by natural products for cancer therapy;The Journal of Nutritional Biochemistry;2024-01

2. A comprehensive role evaluation and mechanism exploration of POGLUT2 in pan-cancer;Frontiers in Oncology;2022-09-08

3. Significant Roles of Notch O-Glycosylation in Cancer;Molecules;2022-03-09

4. The Role of Intracellular Trafficking of Notch Receptors in Ligand-Independent Notch Activation;Biomolecules;2021-09-16

5. Diseases related to Notch glycosylation;Molecular Aspects of Medicine;2021-06